This podcast examines patient centricity in cell and gene therapy, exploring how care must be planned and delivered to be responsive to individual patient preferences, needs and values. What exactly does patient focus mean, when talking about advanced therapies? What should patients know before embarking on this therapy and how do patient advocacy organisations support patients in this process?

Guest:

• Durhane Wong-Rieger, Chair, Rare Disease International Council

Abbreviations:

· HTA: Health Technology Assessment

· ERNs: European Reference Networks